Volume 21, Issue 10 (October 2023)                   Int J Reprod BioMed. 2023, 21(10): 777-788 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bahreiny S S, Ahangarpour A, Hemmati A A, Kazemzadeh R, Bastani M, Dabbagh M R et al . Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis. Int J Reprod BioMed. 2023; 21 (10) :777-788
URL: http://ijrm.ir/article-1-3128-en.html
1- Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Golestan St., Ahvaz, Iran. Postal Code: 61357-15794
2- Medical Basic Sciences Research Institute, Physiology Research Center, Department of Physiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. , akramahangarpour@gmail.com
3- Marine Pharmaceutical Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran ., Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Golestan St., Ahvaz, Iran. Postal Code: 61357-15794
4- Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran., Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Golestan St., Ahvaz, Iran. Postal Code: 61357-15794
Abstract:   (2131 Views)
Background: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in females. Nesfatin-1 is a neuropeptide synthesized in the hypothalamus and other peripheral organs, and there are conflicting opinions about its correlation with PCOS.
Objective: This study aims to investigate the correlation between nesfatin-1 and PCOS and evaluates the effectiveness of nesfatin-1 as a biomarker for the detection of PCOS in women.
Materials and Methods: A systematic review and meta-analysis were conducted to identify pertinent articles from databases such as PubMed, Web of Science, Cochrane, EMBASE, Scopus, and Google Scholar. The standardized mean difference (SMD) and 95% confidence interval (CI) were calculated using a random effects model to compare group outcomes. Additionally, meta-regression and subgroup analysis were performed to elucidate sources of heterogeneity.
Results: The meta-analysis involved 12 studies with 1222 participants, and the findings revealed a significant relationship between PCOS and nesfatin-1 levels. The pooled (SMD = 0.54; 95% CI: 0.00-1.07; p = 0.04) indicated a significant difference between the evaluated groups. Moreover, a subgroup analysis showed that there was a substantial difference in nesfatin-1 levels among women with PCOS and higher homeostatic model assessment for insulin resistance ratio (SMD = 1.46; 95% CI: 0.92-2.00; p < 0.001).
Conclusion: Our meta-analysis indicates an association between high nesfatin-1 levels and PCOS. This suggests a potential role of nesfatin-1 in the development of PCOS and proposes it as a potential diagnostic biomarker for the disease. However, further research is necessary to validate these findings.
Full-Text [PDF 897 kb]   (1539 Downloads) |   |   Full-Text (HTML)  (395 Views)  
Type of Study: Review Article | Subject: Reproductive Endocrinology
* Corresponding Author Address: Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Golestan St., Ahvaz, Iran. Postal Code: 61357-15794

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb